How much does cabozantinib cost in the Indian market?

Cabozantinib is a drug widely used in cancer treatment. It belongs to a class of drugs called multikinase inhibitors, which inhibit the growth and spread of tumors by blocking the activity of multiple targeted proteases. Cabozantinib has been proven to have certain therapeutic effects on a variety of malignant tumors, including renal cell carcinoma, thyroid cancer, and prostate cancer.

Since cabozantinib has not yet been launched in China, domestic patients cannot purchase it directly and must obtain it through overseas channels. In overseas markets, cabozantinib has two options: original drug and generic drug. The price of original drugs is relatively expensive. For example, the price of original drugs in Japan and Europe is about 30,000 to 40,000 yuan; while the price of generic drugs is relatively affordable. For example, the price of generic drugs in Laos, India, Bangladesh and other countries is only in the range of a few hundred to several thousand yuan. It is worth mentioning that the ingredients of these original drugs and generic drugs are basically the same.

The price of Indian generic cabozantinib ranges from a few hundred yuan to one or two thousand yuan, with different specifications and prices.

In the treatment of renal cell carcinoma, cabozantinib is widely used in the first-line and second-line treatment of advanced renal cell carcinoma. It effectively inhibits tumor growth and metastasis by inhibiting tumor angiogenesis and tumor cell proliferation. In addition, cabozantinib can also reduce tumor invasion of bone marrow, relieve bone pain and other symptoms, and improve patients' survival rate and quality of life.

In addition to renal cell carcinoma, cabozantinib is also used to treat other malignancies such as thyroid cancer and prostate cancer. In these cancer types, cabozantinib also inhibits tumor proliferation and spread by targeting tumor-related signaling pathways, thereby prolonging patients' survival and improving their quality of life.

Although cabozantinib has shown certain efficacy in cancer treatment, it may also be accompanied by some side effects, such as high blood pressure, dry mouth, fatigue, etc. Therefore, when using cabozantinib, doctors need to evaluate the patient's specific situation and conduct strict monitoring and management to ensure that the patient can obtain the maximum therapeutic effect while minimizing the occurrence of side effects.